Literature DB >> 26700712

Local and Global Function Model of the Liver.

Hesheng Wang1, Mary Feng2, Andrew Jackson3, Randall K Ten Haken2, Theodore S Lawrence2, Yue Cao4.   

Abstract

PURPOSE: To develop a local and global function model in the liver based on regional and organ function measurements to support individualized adaptive radiation therapy (RT). METHODS AND MATERIALS: A local and global model for liver function was developed to include both functional volume and the effect of functional variation of subunits. Adopting the assumption of parallel architecture in the liver, the global function was composed of a sum of local function probabilities of subunits, varying between 0 and 1. The model was fit to 59 datasets of liver regional and organ function measures from 23 patients obtained before, during, and 1 month after RT. The local function probabilities of subunits were modeled by a sigmoid function in relating to MRI-derived portal venous perfusion values. The global function was fitted to a logarithm of an indocyanine green retention rate at 15 minutes (an overall liver function measure). Cross-validation was performed by leave-m-out tests. The model was further evaluated by fitting to the data divided according to whether the patients had hepatocellular carcinoma (HCC) or not.
RESULTS: The liver function model showed that (1) a perfusion value of 68.6 mL/(100 g · min) yielded a local function probability of 0.5; (2) the probability reached 0.9 at a perfusion value of 98 mL/(100 g · min); and (3) at a probability of 0.03 [corresponding perfusion of 38 mL/(100 g · min)] or lower, the contribution to global function was lost. Cross-validations showed that the model parameters were stable. The model fitted to the data from the patients with HCC indicated that the same amount of portal venous perfusion was translated into less local function probability than in the patients with non-HCC tumors.
CONCLUSIONS: The developed liver function model could provide a means to better assess individual and regional dose-responses of hepatic functions, and provide guidance for individualized treatment planning of RT.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26700712      PMCID: PMC4692182          DOI: 10.1016/j.ijrobp.2015.09.044

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  35 in total

Review 1.  Tolerance of normal tissue to therapeutic irradiation.

Authors:  B Emami; J Lyman; A Brown; L Coia; M Goitein; J E Munzenrider; B Shank; L J Solin; M Wesson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

2.  Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients.

Authors:  A W Hemming; C H Scudamore; C R Shackleton; M Pudek; S R Erb
Journal:  Am J Surg       Date:  1992-05       Impact factor: 2.565

3.  Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.

Authors:  L A Dawson; C J McGinn; D Normolle; R K Ten Haken; S Walker; W Ensminger; T S Lawrence
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

4.  Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?

Authors:  M Fan; L B Marks; D Hollis; G G Bentel; M S Anscher; G Sibley; R E Coleman; R J Jaszczak; M T Munley
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

5.  Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation.

Authors:  E D Yorke; G J Kutcher; A Jackson; C C Ling
Journal:  Radiother Oncol       Date:  1993-03       Impact factor: 6.280

6.  Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation.

Authors:  A Jackson; G J Kutcher; E D Yorke
Journal:  Med Phys       Date:  1993 May-Jun       Impact factor: 4.071

7.  Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury.

Authors:  L J Boersma; E M Damen; R W de Boer; S H Muller; R A Valdés Olmos; N van Zandwijk; J V Lebesque
Journal:  Radiother Oncol       Date:  1995-07       Impact factor: 6.280

8.  Indocyanine green. Its use as an early indicator of hepatic dysfunction following injury in man.

Authors:  M E Gottlieb; H H Stratton; J C Newell; D M Shah
Journal:  Arch Surg       Date:  1984-03

9.  Analysis of radiation-induced liver disease using the Lyman NTCP model.

Authors:  Laura A Dawson; Daniel Normolle; James M Balter; Cornelius J McGinn; Theodore S Lawrence; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

10.  Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma.

Authors:  L J Boersma; E M Damen; R W de Boer; S H Muller; C M Roos; R A Valdés Olmos; N van Zandwijk; J V Lebesque
Journal:  Radiother Oncol       Date:  1994-09       Impact factor: 6.280

View more
  10 in total

1.  Abdominal DCE-MRI reconstruction with deformable motion correction for liver perfusion quantification.

Authors:  Adam Johansson; James M Balter; Yue Cao
Journal:  Med Phys       Date:  2018-08-31       Impact factor: 4.071

2.  Volumetric prediction of breathing and slow drifting motion in the abdomen using radial MRI and multi-temporal resolution modeling.

Authors:  Lianli Liu; Adam Johansson; Yue Cao; Theodore S Lawrence; James M Balter
Journal:  Phys Med Biol       Date:  2021-09-03       Impact factor: 4.174

3.  Implementing Radiation Dose-Volume Liver Response in Biomechanical Deformable Image Registration.

Authors:  Daniel F Polan; Mary Feng; Theodore S Lawrence; Randall K Ten Haken; Kristy K Brock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-06-27       Impact factor: 7.038

4.  Abdominal synthetic CT generation from MR Dixon images using a U-net trained with 'semi-synthetic' CT data.

Authors:  Lianli Liu; Adam Johansson; Yue Cao; Janell Dow; Theodore S Lawrence; James M Balter
Journal:  Phys Med Biol       Date:  2020-06-15       Impact factor: 3.609

5.  Optimizing global liver function in radiation therapy treatment planning.

Authors:  Victor W Wu; Marina A Epelman; Hesheng Wang; H Edwin Romeijn; Mary Feng; Yue Cao; Randall K Ten Haken; Martha M Matuszak
Journal:  Phys Med Biol       Date:  2016-08-12       Impact factor: 3.609

6.  Modeling of Normal Tissue Complications Using Imaging and Biomarkers After Radiation Therapy for Hepatocellular Carcinoma.

Authors:  Issam El Naqa; Adam Johansson; Dawn Owen; Kyle Cuneo; Yue Cao; Martha Matuszak; Latifa Bazzi; Theodore S Lawrence; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-01       Impact factor: 7.038

7.  Modeling intra-fractional abdominal configuration changes using breathing motion-corrected radial MRI.

Authors:  Lianli Liu; Adam Johansson; Yue Cao; Rojano Kashani; Theodore S Lawrence; James M Balter
Journal:  Phys Med Biol       Date:  2021-04-12       Impact factor: 3.609

8.  Gastrointestinal 4D MRI with respiratory motion correction.

Authors:  Adam Johansson; James M Balter; Yue Cao
Journal:  Med Phys       Date:  2021-03-24       Impact factor: 4.506

9.  Evaluation of Pretreatment Magnetic Resonance Elastography for the Prediction of Radiation-Induced Liver Disease.

Authors:  Trey C Mullikin; Kay M Pepin; Jaden E Evans; Sudhakar K Venkatesh; Richard L Ehman; Kenneth W Merrell; Michael G Haddock; William S Harmsen; Michael G Herman; Christopher L Hallemeier
Journal:  Adv Radiat Oncol       Date:  2021-09-09

10.  Gadoxetic Acid Uptake Rate as a Measure of Global and Regional Liver Function as Compared With Indocyanine Green Retention, Albumin-Bilirubin Score, and Portal Venous Perfusion.

Authors:  Josiah Simeth; Madhava Aryal; Dawn Owen; Kyle Cuneo; Theodore S Lawrence; Yue Cao
Journal:  Adv Radiat Oncol       Date:  2022-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.